Greg Abel’s Berkshire Capital Moves: Burry’s Concerns

Recent capital deployment under Greg Abel at Berkshire Hathaway has sparked debate regarding its investment strategy, particularly contrasting with Warren Buffett’s renowned patience. Noted investor Michael Burry voiced his “biggest fear” that Buffett’s successor might prioritize shareholder appeasement over waiting for opportune market moments.

Berkshire’s second-quarter earnings report revealed a reduction in its cash reserves, dropping from a record $380 billion to $365 billion. This significant shift followed 14 consecutive quarters where the conglomerate was a net seller of stocks.

Key Capital Deployments Under Abel

• Net spending on stocks totaled $20 billion, comprising $23.5 billion in new investments against $3.7 billion in sales.
• Share repurchases amounted to $4.6 billion, marking the largest quarterly buyback since 2021, with further buybacks occurring in July.
• Acquisitions included OxyChem for $9.4 billion and Taylor Morrison for $6.8 billion.

Despite these actions, some major moves, like last year’s $10 billion private placement in Alphabet stock and the OxyChem deal, were initiated by Buffett himself. Abel has publicly affirmed his commitment to Buffett’s disciplined capital allocation strategy, consulting with Buffett on significant decisions.

Burry’s central concern focuses on whether Abel is deploying cash primarily to reassure shareholders rather than identifying fundamental bargains. This analytical lens suggests a potential shift in the core investment philosophy that defined Berkshire for decades.

However, it is notable that despite the recent activity, Berkshire’s cash pile at the end of June remained larger than it was a year prior. The question persists whether Abel is truly forging a distinct path or if Burry’s concerns about his patience and potential pandering hold true.